Wayfinding Financial’s Medpace MEDP Stock Holding History

Wayfinding Financial’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-51	Closed	-$15K	–	497
2025 Q1	$15K	Buy	+51	New	+$17.2K	0.01%	622

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Wayfinding Financial's MEDP Position: Q2 2025 in Review

Wayfinding Financial sold out of Medpace (MEDP) in Q2 2025, closing a stake of 51 shares — an estimated $15K sold.

Wayfinding Financial first reported a position in MEDP in Q1 2025 and held it in 1 quarter. The position peaked at $15K in Q1 2025. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

Wayfinding Financial reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
Wayfinding Financial sold 51 Medpace shares in Q2 2025, an estimated $15K.
Wayfinding Financial first reported a position in Medpace in Q1 2025 and held it in 1 quarter.
Wayfinding Financial's Medpace position peaked at $15K in Q1 2025.
602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Wayfinding Financial's 13F filing for Q2 2025, filed 12 Aug 2025.